replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity 
recent studies human immunodeficiency virus type hiv- infection humans simian immunodeficiency virus siv rhesus monkeys shown resolution acute viral infection control subsequent persistent infection mediated antiviral cellular immune response- comparatively assessed several vaccine vector delivery systems-three formulations plasmid dna vector modified vaccinia ankara mva virus replication incompetent adenovirus type ad5 vector-expressing siv gag protein ability elicit immune responses monkeys vaccines tested either single modality combined modality regimens show effective responses elicited replication-incompetent ad5 vector used either alone booster inoculation priming dna vector challenge pathogenic hiv-siv hybrid virus shiv animals immunized ad5 vector exhibited pronounced attenuation virus infection replication-defective adenovirus promising vaccine vector development hiv vaccine 
